Analystreport

Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

SUNESIS PHARMACEUTICALS  (SNSS) 
Last sunesis pharmaceuticals earnings: 3/10 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.sunesis.com/investor-overview